KITE PHARMA INC - COM (KITE) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q4 2017

Type / Class
Equity / COM
Symbol
KITE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of KITE PHARMA INC - COM (KITE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2017 Q4 0 $0 -$8,880,778,823 0
2017 Q3 49,372,145 $8,877,448,808 +$726,181,614 $179.81 241
2017 Q2 50,445,144 $5,226,929,070 +$253,491,603 $103.67 218
2017 Q1 48,526,266 $3,808,237,021 +$573,499,341 $78.49 205
2016 Q4 44,652,587 $2,002,347,126 +$252,906,375 $44.84 180
2016 Q3 38,659,667 $2,158,583,413 +$87,707,810 $55.86 192
2016 Q2 37,671,545 $1,883,952,550 +$31,979,009 $50.00 172
2016 Q1 37,029,820 $1,699,879,745 -$2,328,919 $45.91 168
2015 Q4 36,623,637 $2,256,800,306 +$168,521,486 $61.62 186
2015 Q3 33,615,441 $1,871,779,093 +$190,503,580 $55.68 154
2015 Q2 30,153,746 $1,839,983,350 +$270,583,417 $60.97 155
2015 Q1 25,779,891 $1,486,351,062 +$279,185,833 $57.68 147
2014 Q4 20,804,978 $1,199,798,993 +$492,842,908 $57.67 115
2014 Q3 9,664,984 $272,866,000 +$265,943,219 $28.50 61
2014 Q2 241,193 $6,975,000 +$6,975,000 $28.92 5